Infection Intel: AstraZeneca, DayZero and Oxford Nanopore, and More

News
Article

Staying Ahead with Company Updates and Product Innovations. This week's news is from AstraZeneca, DayZero and Oxford Nanopore, Ohmnilab, and NIH.

Infection Intel: Staying Ahead with Company Updates and Product Innovations.

Infection Intel: Staying Ahead with Company Updates and Product Innovations.

Infection Intel is the column for Infection Control Today® (ICT®) that covers the latest news, including updates on product developments, mergers, and more from companies in the infection control and prevention field.

Recent Videos
Cheron Rojo, BS, FCS, CHL,  CER, CFER, CRCST
Matthias Tschoerner, Dr Sc
Standardizing Cleaning and Disinfection
Concept images of Far-UVC  (Adobe Stock 316993517 by hopenv)
Physicians Sound Alarm: Vaccine Misinformation and Policy Failures Threaten US Public Health
Anna Castillo-Gutierrez, CRCST, CSPDT, CHL, CIS, CFER,  and Maya Luera, CRCST, CIS, CER, CHL
Lucy Witt, MD
Chase Elms, BS, CRCST
Garrett Hollembeak, CRCST, CIS, CHL, CER, CIC
Hannah Schroeder, BSHA, CRCST, CIS, CHL, CER,
Related Content